Literature DB >> 9561840

Transcriptional control of adipogenesis.

L Fajas1, J C Fruchart, J Auwerx.   

Abstract

Adipocyte differentiation is coordinatedly regulated by several transcription factors. C/EBP beta, C/EBP delta and ADD-1/SREBP-1 are active early during the differentiation process and induce the expression and/or activity of the peroxisome proliferator activated receptor-gamma (PPAR gamma), the pivotal coordinator of the adipocyte differentiation process. Activated PPAR gamma induces exit from the cell cycle and triggers the expression of adipocyte-specific genes, resulting in increased delivery of energy to the cells. C/EBP alpha, whose expression coincides with the later stages of differentiation, cooperates with PPAR gamma in inducing additional target genes and sustains a high level of PPAR gamma in the mature adipocyte as part of a feedforward loop. Altered activity and/or expression of these transcription factors might underlie the pathogenesis of disorders characterized by increased or decreased adipose tissue depots.

Entities:  

Mesh:

Year:  1998        PMID: 9561840     DOI: 10.1016/s0955-0674(98)80138-5

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  70 in total

1.  Phenolic compounds from maté (Ilex paraguariensis) inhibit adipogenesis in 3T3-L1 preadipocytes.

Authors:  Grace Gosmann; Adriana Gregory Barlette; Tabitha Dhamer; Demétrius P Arçari; Juliana Carvalho Santos; Eloá Ramalho de Camargo; Simone Acedo; Alessandra Gambero; Simone Cristina Baggio Gnoatto; Marcelo Lima Ribeiro
Journal:  Plant Foods Hum Nutr       Date:  2012-06       Impact factor: 3.921

2.  Frequency and significance of Pro12Ala and Pro115Gln polymorphism in gene for peroxisome proliferation-activated receptor-gamma regarding metabolic parameters in a Caucasian cohort.

Authors:  A Schäffler; N Barth; G Schmitz; B Zietz; K D Palitzsch; J Schölmerich
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

3.  IL-17 regulates adipogenesis, glucose homeostasis, and obesity.

Authors:  Luis A Zúñiga; Wen-Jun Shen; Barbara Joyce-Shaikh; Ekaterina A Pyatnova; Andrew G Richards; Colin Thom; Sofia M Andrade; Daniel J Cua; Fredric B Kraemer; Eugene C Butcher
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

4.  Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.

Authors:  S Sauder; H Kölsch; D Lütjohann; A Schulz; K von Bergmann; W Maier; R Heun
Journal:  J Neural Transm (Vienna)       Date:  2005-01-24       Impact factor: 3.575

5.  Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio) depending on gender and developmental stage.

Authors:  Arantza Ibabe; Eider Bilbao; Miren P Cajaraville
Journal:  Histochem Cell Biol       Date:  2004-12-23       Impact factor: 4.304

Review 6.  Pharmacological agents for NASH.

Authors:  Vlad Ratziu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-10-15       Impact factor: 46.802

Review 7.  Implications of adiponectin in linking metabolism to testicular function.

Authors:  Luc J Martin
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

8.  Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis.

Authors:  A Rebbapragada; H Benchabane; J L Wrana; A J Celeste; L Attisano
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  A mixture of the aqueous extract of Garcinia cambogia, soy peptide and L: -carnitine reduces the accumulation of visceral fat mass in rats rendered obese by a high fat diet.

Authors:  Yun Jung Kim; Keun-Young Kim; Min Sun Kim; Jin Hee Lee; Kang Pyo Lee; Taesun Park
Journal:  Genes Nutr       Date:  2008-02       Impact factor: 5.523

Review 10.  The changing balance between osteoblastogenesis and adipogenesis in aging and its impact on hematopoiesis.

Authors:  Monique Bethel; Brahmananda R Chitteti; Edward F Srour; Melissa A Kacena
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.